Cellectis Ads Each Repr 1 Ord Spon盘中异动早盘快速下挫9.40%

自选股智能写手05-07

北京时间2024年05月07日21时31分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现波动，股价快速下跌9.40%。截至发稿，该股报3.04美元/股，成交量2.8315万股，换手率0.04%，振幅2.09%。最近的财报数据显示，该股实现营业收入755000.00美元，净利润-1.09亿美元，每股收益-1.77美元，毛利-18.47百万美元，市盈率...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2433850788?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-05-07 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2433850788","market":"us","top_or_hot":-1,"title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘快速下挫9.40%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年05月07日21时31分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现波动，股价快速下跌9.40%。截至发稿，该股报3.04美元/股，成交量2.8315万股，换手率0.04%，振幅2.09%。最近的财报数据显示，该股实现营业收入755000.00美元，净利润-1.09亿美元，每股收益-1.77美元，毛利-18.47百万美元，市盈率...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721313687dc9d85&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘快速下挫9.40%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCellectis Ads Each Repr 1 Ord Spon盘中异动 早盘快速下挫9.40%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-07 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721313687dc9d85&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年05月07日21时31分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现波动，股价快速下跌9.40%。截至发稿，该股报3.04美元/股，成交量2.8315万股，换手率0.04%，振幅2.09%。最近的财报数据显示，该股实现营业收入755000.00美元，净利润-1.09亿美元，每股收益-1.77美元，毛利-18.47百万美元，市盈率...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721313687dc9d85&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721313687dc9d85&s=b","article_id":"2433850788","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721313687dc9d85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2433850788","pubTimestamp":1715088696,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年05月07日21时31分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价快速下跌9.40%。截至发稿，该股报3.04美元/股，成交量2.8315万股，换手率0.04%，振幅2.09%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.74%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家专注于癌症免疫疗法开发的生物技术公司。Cellectis利用战略合作伙伴关系以及通过各种大学临床中心的合作。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","CLLS":"Cellectis S.A."},"translate_title":"Cellectis Ads Each Repr 1 Ord Spon fell 9.40% in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLLS":0.9},"content_text":"北京时间2024年05月07日21时31分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现波动，股价快速下跌9.40%。截至发稿，该股报3.04美元/股，成交量2.8315万股，换手率0.04%，振幅2.09%。最近的财报数据显示，该股实现营业收入755000.00美元，净利润-1.09亿美元，每股收益-1.77美元，毛利-18.47百万美元，市盈率-1.71倍。机构评级方面，在所有5家参与评级的机构中，60%的券商给予买入建议，40%的券商给予持有建议，无券商给予卖出建议。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Clearmind Medicine Inc.、Geovax Labs Inc C/Wts 29/09/2025(To Pur Com)、Nanoviricides, Inc.涨幅较大，Clearmind Medicine Inc.、Tc Biopharm (Holdings) Plc、Allarity Therapeutics, Inc.较为活跃，换手率分别为818.73%、92.39%、30.66%，振幅较大的相关个股有Clearmind Medicine Inc.、Nanoviricides, Inc.、Pliant Therapeutics, Inc.，振幅分别为12.82%、12.14%、8.47%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家专注于癌症免疫疗法开发的生物技术公司。该公司参与基因编辑，试图引导人体免疫系统攻击癌细胞。Cellectis利用战略合作伙伴关系以及通过各种大学临床中心的合作。该公司的基因编辑技术允许从健康的捐赠者而不是患者自己身上创造健康的细胞。报告分为两部分:治疗学和植物学。它的治疗部门专注于新颖的癌症疗法，而它的植物部门专注于农业生物技术。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2433850788"}

Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘快速下挫9.40%

精彩评论

Cellectis Ads Each Repr 1 Ord Spon盘中异动早盘快速下挫9.40%